Budapest, Hungary

Katalin Goldschmidt Nee Horvath


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Katalin Goldschmidt nee Horvath

Introduction

Katalin Goldschmidt nee Horvath is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on benzodiazepine derivatives. With one patent to her name, she has demonstrated her commitment to advancing therapeutic treatments that offer valuable benefits to patients.

Latest Patents

Katalin Goldschmidt holds a patent for a novel compound known as the 5H-benzodiazepin derivative. This invention relates specifically to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine and its pharmaceutically acceptable acid addition salts. The patent outlines a process for preparing these compounds, which are noted for their anxiolytic, antiaggressive, and antidepressant effects. Moreover, the compounds have favorable acute toxicity values, making them advantageous for therapeutic applications.

Career Highlights

Throughout her career, Katalin has worked at Egis Gyógyszergyár, a well-known pharmaceutical manufacturer in Hungary. Her work in this leading company has allowed her to bring her innovative ideas to fruition, contributing to the development of new therapies aimed at improving mental health and well-being.

Collaborations

Katalin Goldschmidt has collaborated with several colleagues, including Ferenc Andrasi and Peter Botka. These partnerships highlight the importance of teamwork in the field of innovation and showcase the collective efforts needed to bring groundbreaking ideas to life.

Conclusion

Katalin Goldschmidt nee Horvath's contributions to the pharmaceutical industry through her innovative inventions underscore her dedication to improving therapeutic outcomes. Her patented work on benzodiazepine derivatives not only reflects her ingenuity but also her commitment to enhancing patient care in the realm of mental health. With a strong foundation in research and collaboration, Katalin continues to inspire future innovations in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…